Bupropion and Naltrexone in Methamphetamine Use Disorder
2021 · New England Journal of Medicine · 242 citations
https://doi.org/10.1056/nejmoa2020214
P
Phillip O. Coffin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
211
Papers
6.1K
Citations
41
h-index
105
i10-index
Phillip O. Coffin is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Opioid Use Disorder Treatment & HIV, Drug Use, Sexual Risk & Substance Abuse Treatment and Outcomes. The author has an h-index of 41, co-authored 180 publications.
ORCID: 0000-0002-3891-6570Papers by this author
worksIdentifying Injection Drug Users at Risk of Nonfatal Overdose
2007 · Academic Emergency Medicine · 154 citations
https://doi.org/10.1197/j.aem.2007.04.005
Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men
2019 · JAMA Psychiatry · 119 citations
https://doi.org/10.1001/jamapsychiatry.2019.3655
Aripiprazole for the treatment of methamphetamine dependence: a randomized, double‐blind, placebo‐controlled trial
2012 · Addiction · 60 citations
https://doi.org/10.1111/add.12073
Emergency department visits and trends related to cocaine, psychostimulants, and opioids in the United States, 2008–2018
2022 · BMC Emergency Medicine · 35 citations
https://doi.org/10.1186/s12873-022-00573-0
Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs
2019 · PLoS ONE · 29 citations
https://doi.org/10.1371/journal.pone.0217471
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat